Terms of Service
These Terms of Service govern the use of the Vitruvian Shield platform and related services provided by Vitruvian Shield Holding SA (CHE-380.090.655), Epalinges, Switzerland ("Vitruvian Shield", "we", "us"). By subscribing to, accessing or using the Services, the customer organisation ("Customer", "you") agrees to these Terms. An order form, quotation or service agreement signed by both parties takes precedence over these Terms where they differ.
1. Acceptance and scope
1.1 Agreement. By subscribing to, accessing or using the Services you enter into a binding agreement with Vitruvian Shield. The person accepting these Terms on behalf of an organisation confirms that they have the authority to bind it.
1.2 Services. The Services comprise the Vitruvian Shield platform (ePRO, remote patient monitoring with wearable and connected-device integration, eConsent, electronic data capture, clinical trial management, and AI analytics once released, which is in development today), hosting and data processing for the platform, and the professional services described in an order form, such as study operation at the service level agreed.
1.3 Capabilities in development. Platform capabilities that the website or documentation describes as in development, in validation or planned, including AI-assisted features and clinical-decision-support AI, are not part of the Services until they are made available to the Customer under an order form.
2. Orders, fees and price changes
2.1 Fees. Fees are those set out in the Customer's order form or quotation. No price is published on this website; fees are set out per engagement in a written proposal.
2.2 Currency and taxes. Fees are stated in Swiss francs (CHF) unless the order form states otherwise, and exclude value added tax and other applicable taxes, duties and government fees, which the Customer bears.
2.3 Price changes. Annual price increases for recurring fees are limited to 5% or the Swiss consumer price index, whichever is lower, with 60 days' advance notice. There are no increases during the initial contract term.
3. Payment and billing
3.1 Billing. Recurring fees are invoiced in advance for the billing period stated in the order form; usage-based fees are calculated monthly on actual usage.
3.2 Payment. Invoices are payable by bank transfer within 30 days unless the order form states otherwise.
3.3 Late payment. Overdue amounts bear interest of 1.5% per month after a 30-day grace period. Services may be suspended for non-payment as described in section 6.
4. Data protection and compliance
4.1 Roles. The Customer is the controller of the personal data processed in the Services and retains ownership of all Customer Data. Vitruvian Shield processes personal data solely on the Customer's documented instructions, under a separate data processing agreement.
4.2 Compliance posture. The platform is designed to support the requirements of the EU General Data Protection Regulation, the Swiss Federal Act on Data Protection (revFADP), ALCOA++ data-integrity principles, FDA 21 CFR Part 11 and ICH E6(R3). No certificate has been issued to date. ISO 27001: implementation in progress. The current status of each framework is published in the Trust Portal.
4.3 Security. Customer Data is encrypted in transit and at rest, access is protected by multi-factor authentication and role-based access control, and data is backed up regularly. Vitruvian Shield notifies the Customer of a personal data breach without undue delay so that the Customer can meet its own notification obligations.
4.4 Hosting and sub-processors. Customer Data is hosted on Microsoft Azure in the European Union by default. Sub-processors are listed in the Trust Portal; the data processing agreement governs changes to that list.
5. Acceptable use
5.1 Permitted uses. The Services may be used for clinical research, including decentralised and hybrid clinical trials, post-market clinical follow-up and registries, remote monitoring for research purposes, academic research and, subject to appropriate consents, the development of analytical models on study data.
5.2 Prohibited uses. You may not use the Services for medical diagnosis or treatment decisions without appropriate medical oversight; breach applicable healthcare regulations or clinical trial protocols; reverse engineer, decompile or create derivative works of the Services; use the Services to build competing products; share user credentials or sublicense access to third parties; or breach any applicable law, regulation or ethical guideline.
5.3 Customer obligations. The Customer obtains the required participant consents before data collection, maintains the required regulatory and ethics committee approvals, ensures that its authorised users are trained, and reports adverse events and protocol deviations as required by applicable regulations.
6. Term, renewal and termination
6.1 Term. Unless the order form states otherwise, the initial term is one year from service activation and renews automatically for successive one-year periods.
6.2 Termination. Either party may terminate for convenience with 90 days' written notice, or for material breach that is not remedied within 30 days of notice. Services may be suspended 15 days after a payment is due and the agreement terminated 45 days after it is due. Either party may terminate if a regulatory change makes the Services non-compliant for the Customer's use.
6.3 Data export and deletion. For 60 days after termination the Customer may export its data in standard formats (CSV, JSON, HL7 FHIR). Customer Data is then securely deleted, except where applicable law requires its retention.
7. Service levels and support
7.1 Service levels. Availability targets, maintenance windows and any service credits are those stated in the order form. Scheduled maintenance is announced in advance; emergency maintenance is notified as soon as practicable.
7.2 Support. Standard support is provided by email during business hours (09:00 to 17:00 Central European Time, Monday to Friday) and includes software updates and security patches. Priority support, a dedicated account contact and additional training can be agreed in the order form.
8. Intellectual property and feedback
8.1 Ownership. All rights in the Services remain with Vitruvian Shield Holding SA. The Customer retains all rights in Customer Data, including outputs and insights generated from Customer Data for the Customer.
8.2 Licence. The Customer grants Vitruvian Shield a limited licence to use Customer Data to provide the Services and, on an anonymised and aggregated basis only, to improve them.
8.3 Feedback. Suggestions provided by the Customer may be incorporated into the Services without compensation; the Customer retains its rights in any proprietary methodology or process it shares.
9. Warranties and disclaimers
9.1 Our warranties. Vitruvian Shield warrants that the Services will perform substantially as described in the documentation, will be operated in line with the data-integrity principles described in section 4, and will be provided by qualified personnel.
9.2 Customer warranties. The Customer warrants that it has the authority to enter into this agreement, that its use of the Services complies with applicable laws and regulations, and that the required participant consents and approvals are obtained.
9.3 Disclaimer. Except as expressly stated, the Services are provided "as is" and all implied warranties, including merchantability and fitness for a particular purpose, are excluded to the extent permitted by law.
9.4 Medical disclaimer. The Services are not currently CE-marked as a medical device and are provided for research use; they must not be used as the sole basis for medical decisions without appropriate clinical oversight.
10. Limitation of liability
10.1 Cap. Vitruvian Shield's total liability is limited to the amounts paid by the Customer in the twelve months preceding the claim.
10.2 Excluded damages. Neither party is liable for indirect, consequential or punitive damages, including lost profits or lost data.
10.3 Exceptions. These limitations do not apply to personal injury caused by negligence, wilful misconduct or gross negligence, breach of confidentiality, or any liability that cannot be excluded by law.
11. Governing law and disputes
11.1 Governing law. These Terms are governed by Swiss law, excluding its conflict-of-law rules and the United Nations Convention on Contracts for the International Sale of Goods.
11.2 Disputes. The parties first seek to resolve a dispute through good-faith negotiation for 30 days, then through mediation under the Swiss Arbitration Centre rules, and finally by arbitration under the ICC Rules seated in Lausanne, Switzerland, in English.
11.3 Collective actions. To the extent permitted by law, the Customer waives participation in class or collective actions against Vitruvian Shield.
12. General provisions
12.1 Changes. These Terms may be updated with 30 days' notice; continued use after that date constitutes acceptance. The date of the current version is shown at the top of this page.
12.2 Export control. The Customer complies with applicable Swiss and international export control regulations.
12.3 Severability. If a provision is invalid, the remaining provisions remain in force.
12.4 Force majeure. Neither party is liable for delays caused by circumstances beyond its reasonable control, such as natural disasters, pandemics, government action or cyber attacks.
12.5 Assignment. The Customer may not assign the agreement without written consent. Vitruvian Shield may assign it to an affiliate or in a corporate transaction.
12.6 Survival. The provisions on intellectual property, confidentiality, limitation of liability and dispute resolution survive termination.
12.7 Entire agreement. These Terms, together with the order form and the data processing agreement, form the entire agreement between the parties.
13. Use of this website
The information on this website is provided for general information about Vitruvian Shield and its services. It is not medical advice and does not form an offer; capability statuses and indicative timeframes may change and are confirmed in a written proposal or order form.
14. Contact
Legal notices: legal@vitruvianshield.com. General enquiries: contact@vitruvianshield.com.
Vitruvian Shield Holding SA, Rue de la Corniche 3a, 1066 Epalinges, Switzerland.